Your Health, We Care
Tivozanib is indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.
from FDA，2021.03
Recurrent or refractory advanced renal cell carcinoma (RCC) after two or more pr···【more】
Release date：2026-01-05Recommended：12
